Get started
Author

Sibusiso Tebogo Malindisa

Observed names: Malindisa, Sibusiso T., Sibusiso Malindisa, Sibusiso T Malindisa, Sibusiso T. Malindisa
ORCID: 0000-0002-9287-9408
Observed ORCID: 0000-0002-9287-9408
OpenAlex ID: A5023788478
Two-Dimensional (2D) and Three-Dimensional (3D) Cell Culturing in Drug Discovery
2019 · Jitcy Saji Joseph, Sibusiso Tebogo Malindisa, et al. · IntechOpen eBooks · 101
PDF
The Tumor Microenvironment Factors That Promote Resistance to Immune Checkpoint Blockade Therapy
2021 · Bonnie L. Russell, Selisha A. Sooklal, et al. · Frontiers in Oncology · 81
PDF
Drosophila melanogaster: A platform for anticancer drug discovery and personalized therapies
2022 · Chamoné Munnik, Malungi P. Xaba, et al. · Frontiers in Genetics · 77
PDF
Novel patented therapeutic approaches targeting the 37/67 kDa laminin receptor for treatment of cancer and Alzheimer’s disease
2015 · Katarina Jovanovic, Carryn J Chetty, et al. · Expert Opinion on Therapeutic Patents · 47
Synthesis, Evaluation for Cytotoxicity and Molecular Docking Studies of Benzo[c]furan-Chalcones for Potential to Inhibit Tubulin Polymerization and/or EGFR-Tyrosine Kinase Phosphorylation
2018 · Malose J. Mphahlele, Marole M. Maluleka, et al. · International Journal of Molecular Sciences · 46
PDF
Knock-Down of the 37kDa/67kDa Laminin Receptor LRP/LR Impedes Telomerase Activity
2015 · Kerrilyn Naidoo, Sibusiso T. Malindisa, et al. · PLoS ONE · 29
PDF
Evaluation of Phytochemicals, Antioxidants, Trace Elements in Kigelia africana Fruit Extracts and Chemical Profiling Analysis Using UHPLC-qTOF-MS2 Spectrometry
2019 · Oladapo F. Fagbohun, Olusegun O. Babalola, et al. · Biological Trace Element Research · 27
37 kDa LRP::FLAG enhances telomerase activity and reduces senescent markersin vitro
2017 · Tyrone C. Otgaar, Eloise Ferreira, et al. · Oncotarget · 18
Role of CaMKII in the regulation of fatty acids and lipid metabolism
2021 · Jitcy S. Joseph, Krishnan Anand, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 16
Biological evaluation the 2‐aryl‐2,3‐dihydrobenzodiazaborinin‐4(1H)‐ones as potential dual α‐glucosidase and α‐amylase inhibitors with antioxidant properties
2021 · Malose J. Mphahlele, Nontokozo M. Magwaza, et al. · Chemical Biology & Drug Design · 10
Exercise, CaMKII, and type 2 diabetes
2020 · Joseph, Jitcy S., Anand, Krishnan, et al. · EXCLI journal · 9
PDF
Ezetimibe Anticancer Activity via the p53/Mdm2 Pathway
2025 · Charmy Twala, Sibusiso Malindisa, et al. · Biomedicines · 4
PDF
Number Concentrations and Size Distributions of Chalk Particles Released During Writing and Wiping Activities in Classrooms in the Johannesburg Region
2026 · Setlamorago Jackson Mbazima, Sibusiso Tebogo Malindisa, et al. · Indoor Air · 1
Current Advances in Immune Checkpoint Therapy
2023 · Bonnie L. Russell, Sibusiso T. Malindisa, et al. · IntechOpen eBooks · 1
PDF
Genetic insights on the role of telomere dynamics in Chronic Kidney Disease (CKD) regardless of HIV status
2016 · Sibusiso T. Malindisa · 1
RBBP6 Interaction with the p53–MDM2 Complex Supports Plerixafor-Based Anticancer Targeting
2026 · Sibusiso T. Malindisa, Bonnie L. Russell, et al. · Research Square
PDF
Ezetimibe anticancer activity via the p53/Mdm2 pathway: Implications for RBBP6
2024 · Charmy Twala, Bonnie Russell, et al. · Research Square
PDF
Works count: 18
Citation count: 468
H-index: 10
I10-index: 10
Year
Topic
Type